Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - EyePoint Pharmaceuticals, Inc. | StockGist | StockGist

Companies
EYPT
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings EYPTSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

EyePoint Pharmaceuticals, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001314102

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

82,787,220

Reporting Person

EyePoint Pharmaceuticals, Inc.

Person Type

OO

CUSIP: 30233G209

Key Facts

Shares Owned

82,787,220

Recent Filings

EyePoint Pharmaceuticals, Inc.1 months ago

EyePoint Pharmaceuticals, Inc.1 months ago

EyePoint Pharmaceuticals, Inc.1 months ago

EyePoint Pharmaceuticals, Inc.1 months ago

EyePoint Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice